Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viking Therapeutics (VKTX)
NASDAQ:VKTX
Viking Therapeutics (VKTX) Stock Price & Analysis
2,115 Followers
VKTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.54 - $25.72
Previous Close$13.01
Volume2.95M
Average Volume (3M)2.05M
Market Cap
$1.30B
Enterprise Value$926.47M
Total Cash (Recent Filing)$376.24M
Total Debt (Recent Filing)$1.34M
Price to Earnings (P/E)-14.1
Beta1.57
Next Earnings
Feb 07, 2024EPS Estimate
-$0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.92
Shares Outstanding100,028,953
10 Day Avg. Volume1,455,611
30 Day Avg. Volume2,050,374
Standard Deviation0.24
R-Squared0.02
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)3.53
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-16.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-15.77
Forecast
1Y Price Target
$34.00Price Target Upside161.34% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Viking Therapeutics News
Ownership Overview
8.98% Insiders
24.99% Mutual Funds
34.42% Other Institutional Investors
31.62% Public Companies and Individual Investors
VKTX FAQ
What was Viking Therapeutics’s price range in the past 12 months?
Viking Therapeutics lowest stock price was $3.54 and its highest was $25.72 in the past 12 months.
What is Viking Therapeutics’s market cap?
Currently, no data Available
When is Viking Therapeutics’s upcoming earnings report date?
Viking Therapeutics’s upcoming earnings report date is Feb 07, 2024 which is in 65 days.
How were Viking Therapeutics’s earnings last quarter?
Viking Therapeutics released its earnings results on Oct 25, 2023. The company reported -$0.23 earnings per share for the quarter, missing the consensus estimate of -$0.219 by -$0.011.
Is Viking Therapeutics overvalued?
According to Wall Street analysts Viking Therapeutics’s price is currently Undervalued.
Does Viking Therapeutics pay dividends?
Viking Therapeutics does not currently pay dividends.
What is Viking Therapeutics’s EPS estimate?
Viking Therapeutics’s EPS estimate is -$0.26.
How many shares outstanding does Viking Therapeutics have?
Viking Therapeutics has 100,028,950 shares outstanding.
What happened to Viking Therapeutics’s price movement after its last earnings report?
Viking Therapeutics reported an EPS of -$0.23 in its last earnings report, missing expectations of -$0.219. Following the earnings report the stock price went down -9.466%.
Which hedge fund is a major shareholder of Viking Therapeutics?
Among the largest hedge funds holding Viking Therapeutics’s share is Viking Global Investors LP. It holds Viking Therapeutics’s shares valued at 51M.
---
Viking Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$34.00 (161.34% Upside)
$34.00 (161.34% Upside)
Blogger Sentiment
Bullish
VKTX Sentiment 86%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 791.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.8%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
215.01%
12-Months-Change
Fundamentals
Return on Equity
-31.12%
Trailing 12-Months
Asset Growth
129.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Viking Therapeutics
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. The company's clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
---
Top 5 ETFs holding VKTX
Vanguard Total Stock Market ETF
$27.59M
Vanguard Health Care ETF
$3.02M
Schwab U.S. Broad Market ETF
$662.24K
Vanguard U.S. Momentum Factor ETF
$309.51K
Vanguard Russell 3000 ETF
$60.28K
Up to five ETFs with an Outperform Smart Score that hold VKTX. The ETFs are listed according to market value of VKTX within the ETF
---